Apart from the official phase 2 trial, they are testing dara on additional patients. This is from an updated protocol where everything is unblinded.
Thanks for posting this. It would be nice to know if any of these patients were not female (i.e. males!).
The response by week 2 doesn’t jibe with the response timeline of the initial 6 patients.